{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:58:41Z","timestamp":1770915521244,"version":"3.50.1"},"reference-count":19,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2013,3,13]]},"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Inhaled nitric oxide has been reported to benefit patients with acute pulmonary embolism (PE). To date, all published literature has derived from case reports or case series conducted without a structured protocol. Here we report the results of a phase I trial with a predefined clinical protocol to treat patients with CT-demonstrated, submassive PE and moderate to severe dyspnoea.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients were recruited from the emergency department of an academic teaching hospital. Informed consent and the entire treatment protocol was administered by a study physician. Nitric oxide was administered using a commercial device (Inovent) and a custom-made non-rebreathing face mask. The NO concentration was increased at 1\u2005ppm\/min (parts per million) until a maximum of 25\u2005ppm and continued for 120\u2005min and then weaned at 1\u2005ppm\/min. Dyspnoea was assessed with the Borg score, oxygenation by pulse oximetry, and haemodynamic status by shock index (HR\/SBP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight patients were enrolled. All patients tolerated the entire protocol without adverse events, and all had decreased numerical Borg score by &gt;50%. The changes from baseline to 155\u2005min were as follows: Borg score 7.5\u00b12.5 to 2.3\u00b11.9 (p=0.06, Signed rank test), SaO2% 93\u00b15 to 97\u00b13 and shock index 1.0\u00b10.11 to 0.86\u00b10.09. No patient experienced worsening during weaning.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Inhaled NO reduced dyspnoea without adverse events in eight patients with severe submassive PE. This protocol can serve as the basis for a phase II trial or for a compassionate use protocol.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2013-202426","type":"journal-article","created":{"date-parts":[[2013,4,14]],"date-time":"2013-04-14T00:50:10Z","timestamp":1365900610000},"page":"459-462","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Pilot study of a protocol to administer inhaled nitric oxide to treat severe acute submassive pulmonary embolism"],"prefix":"10.1136","volume":"31","author":[{"given":"Jeffrey A","family":"Kline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackeline","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan E","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,4,13]]},"reference":[{"key":"2024052700324244000_31.6.459.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00168-1"},{"key":"2024052700324244000_31.6.459.2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00283.2002"},{"key":"2024052700324244000_31.6.459.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03535.x"},{"key":"2024052700324244000_31.6.459.4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0658"},{"key":"2024052700324244000_31.6.459.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.77.2.353"},{"key":"2024052700324244000_31.6.459.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.071"},{"key":"2024052700324244000_31.6.459.7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/pch\/17.2.95","article-title":"Inhaled nitric oxide use in newborns","volume":"17","author":"Peliowski","year":"2012","journal-title":"Paediatr Child Health"},{"key":"2024052700324244000_31.6.459.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-2725"},{"key":"2024052700324244000_31.6.459.9","doi-asserted-by":"crossref","unstructured":"Afshari A Brok J Moller AM . Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev 2010; Jul 7(7): CD002787.","DOI":"10.1002\/14651858.CD002787.pub2"},{"key":"2024052700324244000_31.6.459.10","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.01373"},{"key":"2024052700324244000_31.6.459.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-005-2550-7"},{"key":"2024052700324244000_31.6.459.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-9-199405010-00007"},{"key":"2024052700324244000_31.6.459.13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0310057X9902700415","article-title":"Use of inhaled nitric oxide in pulmonary embolism","volume":"27","author":"Crerar-Gilbert","year":"1999","journal-title":"Anaesth Intensive Care"},{"key":"2024052700324244000_31.6.459.14","first-page":"710","article-title":"Inhaled nitric oxide in a patient with severe pulmonary embolism","volume":"33","author":"Schenk","year":"1999","journal-title":"Ann Em Med"},{"key":"2024052700324244000_31.6.459.15","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050461"},{"key":"2024052700324244000_31.6.459.16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.1.296"},{"key":"2024052700324244000_31.6.459.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03724.x"},{"key":"2024052700324244000_31.6.459.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-1767(00)90093-X"},{"key":"2024052700324244000_31.6.459.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03704.x"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2013-202426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T07:32:50Z","timestamp":1716795170000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2013-202426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,13]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,5,16]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1136\/emermed-2013-202426"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2013-202426","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,13]]}}}